|
EIF4G3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62873999999258E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.12190000000012E-05 |
| Normal-vs-Stage2 |
4.197000E-04 |
| Normal-vs-Stage3 |
1.79129999999805E-06 |
| Normal-vs-Stage4 |
2.19669999999006E-05 |
| Stage1-vs-Stage2 |
8.021000E-01 |
| Stage1-vs-Stage3 |
9.999600E-02 |
| Stage1-vs-Stage4 |
2.904800E-01 |
| Stage2-vs-Stage3 |
3.830800E-01 |
| Stage2-vs-Stage4 |
5.995200E-01 |
| Stage3-vs-Stage4 |
7.604200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66108999999359E-05 |
| Normal-vs-AfricanAmerican |
1.368800E-04 |
| Normal-vs-Asian |
1.790750E-01 |
| Caucasian-vs-AfricanAmerican |
9.665000E-01 |
| Caucasian-vs-Asian |
7.445000E-01 |
| AfricanAmerican-vs-Asian |
7.402800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3984000000189E-06 |
| Normal-vs-Female |
3.616100E-04 |
| Male-vs-Female |
8.544900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.192600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.006580E-04 |
| Normal-vs-Age(61-80Yrs) |
3.83449999996621E-06 |
| Normal-vs-Age(81-100Yrs) |
4.53280000001222E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.844400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.016400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.864200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.677820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.758200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.238760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.307200E-01 |
| Normal-vs-Grade 2 |
2.764800E-04 |
| Normal-vs-Grade 3 |
3.49739999960796E-07 |
| Normal-vs-Grade 4 |
2.00859999999192E-05 |
| Grade 1-vs-Grade 2 |
7.070200E-02 |
| Grade 1-vs-Grade 3 |
7.551900E-04 |
| Grade 1-vs-Grade 4 |
1.134300E-02 |
| Grade 2-vs-Grade 3 |
1.863690E-03 |
| Grade 2-vs-Grade 4 |
1.307960E-01 |
| Grade 3-vs-Grade 4 |
5.041200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.775600E-04 |
| Normal-vs-ccB subtype |
4.28490000004E-06 |
| ccA subtype-vs-ccB subtype |
2.810300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.82656999999642E-05 |
| Normal-vs-N1 |
3.674000E-02 |
| N0-vs-N1 |
9.245600E-01 |
|
|
